View outcomes graphs.
Access Med-IQ's CME/CE programs.
Sign up to receive e-mail alerts about our new interactive activities.
Questions? Contact our call center toll-free at 866 858 7434 or e-mail info@med-iq.com. |
BALTIMORE, Md.—October 2, 2012—To help healthcare professionals improve the care of their patients with multiple sclerosis (MS), Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), sponsored eight complimentary, regional CME/CE workshops designed for nurse practitioners, physician assistants, and nurses in the Fall of 2011. More than 290 clinicians attended across all eight workshops, and educational outcomes demonstrate favorable change in knowledge and competence as a result of the intervention.
The workshops were designed to be interactive, combining didactic presentations with small-group discussions that focused on patient cases, clinical trial data, and the latest diagnostic criteria and treatment recommendations for MS. Of the 293 participants, 36% were nurse practitioners, 25% were physicians, 19% were nurses, 14% were physician assistants, and 6% were other healthcare professionals.
Med-IQ is committed to measuring and evaluating the effects of its educational activities to improve healthcare professional competencies that directly affect patient care and the patient experience. At each workshop, participants’ knowledge/competence was assessed before and directly after the activity to measure immediate learning and changes in competence when compared with baseline data (Moore’s Level 4). Highlights of the results show statistically significant changes in participant knowledge and competence across a broad range of patient-care topics.
Confidence in participants’ ability to select optimal therapies for patients with MS and to use neuroimaging/neurodiagnostic techniques to correlate the clinical and immunologic effects of MS therapies were also assessed before and after the activity. Results showed a positive change in participants’ confidence in both areas. As a result of the educational intervention, attendees* noted their intent to implement the following practice changes:
- I will consider recent evidence on the impact of early pharmacologic intervention on disease progression when making management decisions for my patients with MS (28%)
- I will incorporate clinical follow-up and imaging techniques to identify and assess therapeutic response to DMT in my patients with MS (20%)
- I will use a comprehensive approach when evaluating and treating patients for MS-related symptoms (41%)
*N = 377; participants were able to select more than one anticipated practice change
In addition, participants’ knowledge/competence was reassessed 30 days after the live activities were completed to measure retained learning and longer-term changes in knowledge and competence. Highlights of the findings show that, across most areas, participants who completed all three survey assessments demonstrated higher levels of knowledge and competence at the 30-day mark than they did before the educational intervention.
Based on the success of this 2011 series, Med-IQ sponsored eight additional MS CME/CE workshops in the spring of 2012.
"Live, facilitated meetings offer peer-to-peer interaction that is critical to participants’ ongoing professional education, provide the opportunity to gain valuable insight into how peers address or overcome typical barriers to patient care, and enable participants to interact with and learn from subject matter experts," said William A. Mencia, MD, CCMEP, Vice President of Education & Medical Affairs at Med-IQ. "Med-IQ is committed to improving healthcare quality in the United States by providing accessible, practice-focused CME/CE interventions such as this that are timely, effective, and relevant to clinicians’ needs and that address the issues that will lead to better patient care and reduced healthcare utilization."
This activity was supported by an educational grant from Teva Pharmaceuticals.
This program was approved for 2.0 contact hours of continuing education by the American Academy of Nurse Practitioners, reviewed and approved for a maximum of two hours of AAPA Category I CME credit by the Physician Assistant Review Panel, and approved for AMA PRA Category 1 Credit™ and CBRN credit.
|
About Med-IQ
Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ received the Alliance for Continuing Education in the Health Professions' President’s Award (2012), Award for Outstanding CME Outcomes Assessment (2012), and William Campbell Felch Award for Outstanding Research in CME (2011). Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively. We are a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives. To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, connect with us on LinkedIn, and visit our YouTube channel.
For more information, contact: |
close
